Fractalkine, sICAM-1 and Kynurenine Pathway in Restrictive Anorexia Nervosa-Exploratory Study.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
24 Jan 2021
Historique:
received: 15 11 2020
revised: 20 01 2021
accepted: 20 01 2021
entrez: 27 1 2021
pubmed: 28 1 2021
medline: 3 9 2021
Statut: epublish

Résumé

The link between the kynurenine pathway and immunomodulatory molecules-fractalkine and soluble intercellular adhesion molecule-1 (sICAM-1)-in anorexia nervosa (AN) remains unknown. Fractalkine, sICAM-1, tryptophan (TRP), kynurenine (KYN), neuroprotective kynurenic acid (KYNA), neurotoxic 3-OH-kynurenine (3-OH-KYN), and the expression of mRNA for kynurenine aminotransferases (

Identifiants

pubmed: 33498837
pii: nu13020339
doi: 10.3390/nu13020339
pmc: PMC7910978
pii:
doi:

Substances chimiques

Chemokine CX3CL1 0
ICAM1 protein, human 0
RNA, Messenger 0
Intercellular Adhesion Molecule-1 126547-89-5
3-hydroxykynurenine 27723548JL
Kynurenine 343-65-7
Tryptophan 8DUH1N11BX
Transaminases EC 2.6.1.-
kynurenine-oxoglutarate transaminase EC 2.6.1.7
Kynurenic Acid H030S2S85J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical University in Lublin
ID : DS 450/17, 450/18, 450/19, 450/20

Références

J Neurochem. 2005 May;93(3):762-5
pubmed: 15836634
J Neurosci Res. 1997 Nov 1;50(3):457-65
pubmed: 9364331
Pharmacol Res. 2016 Jan;103:1-12
pubmed: 26535964
J Investig Med. 2017 Feb;65(2):333-337
pubmed: 27658415
J Affect Disord. 2007 Feb;98(1-2):143-51
pubmed: 16952400
Neuropharmacology. 2014 Jul;82:11-8
pubmed: 24607890
Behav Pharmacol. 2012 Sep;23(5-6):478-95
pubmed: 22854305
Int J Tryptophan Res. 2009;2:1-19
pubmed: 22084578
Int J Eat Disord. 2003 Apr;33(3):257-67; discussion 268-70
pubmed: 12655621
Metabolism. 2015 Mar;64(3):396-405
pubmed: 25500208
Mol Psychiatry. 2020 Jan;25(1):131-147
pubmed: 30980044
Nutrients. 2020 Aug 27;12(9):
pubmed: 32867089
Biomed Rep. 2017 Aug;7(2):188-192
pubmed: 28804633
Schizophr Bull. 2018 Jan 13;44(1):75-83
pubmed: 28338954
Behav Brain Res. 2017 Sep 15;334:119-128
pubmed: 28736330
Front Pharmacol. 2019 Nov 22;10:1251
pubmed: 31824303
Int J Eat Disord. 2015 Nov;48(7):826-41
pubmed: 26311090
J Psychiatr Res. 2018 Aug;103:252-264
pubmed: 29906710
Brain Behav Immun. 2020 Aug;88:718-724
pubmed: 32389698
Life Sci. 2017 Jun 1;178:87-93
pubmed: 28438641
Cell. 2014 Sep 25;159(1):33-45
pubmed: 25259918
J Clin Med. 2019 Nov 08;8(11):
pubmed: 31717370
Psychoneuroendocrinology. 2014 Jan;39:170-178
pubmed: 24135616
Int J Mol Sci. 2019 May 09;20(9):
pubmed: 31075818
Front Neurosci. 2016 Jun 29;10:256
pubmed: 27445651
Eur Cytokine Netw. 2004 Apr-Jun;15(2):91-8
pubmed: 15319166
Eur J Clin Nutr. 2002 Aug;56 Suppl 3:S34-7
pubmed: 12142959
Biol Psychiatry. 1995 Apr 15;37(8):512-20
pubmed: 7542489
Eur J Clin Invest. 2015 Jul;45(7):670-8
pubmed: 25944525
Eur J Neurosci. 2001 Jun;13(11):2141-7
pubmed: 11422455
Neurotox Res. 2017 Jul;32(1):17-26
pubmed: 28275903
CNS Neurol Disord Drug Targets. 2017;16(4):440-453
pubmed: 28412922
Transl Psychiatry. 2019 Jun 4;9(1):159
pubmed: 31164627
Psychol Med. 1989 Nov;19(4):857-64
pubmed: 2594882
J Neuroinflammation. 2011 Jan 25;8:9
pubmed: 21266082
Curr Top Behav Neurosci. 2017;31:95-115
pubmed: 27278641
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:304-13
pubmed: 24184687
Curr Neuropharmacol. 2016;14(7):705-20
pubmed: 26893168
J Psychiatr Res. 2013 Nov;47(11):1815-23
pubmed: 24012176
Sci Rep. 2020 Jan 23;10(1):1078
pubmed: 31974503
Open Biol. 2013 Dec 18;3(12):130181
pubmed: 24352739
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Sci Rep. 2016 Feb 24;6:21887
pubmed: 26906060
Psychoneuroendocrinology. 2003 Apr;28(3):229-49
pubmed: 12573293
Nutrients. 2018 Oct 24;10(11):
pubmed: 30355978
Int J Mol Sci. 2020 Apr 30;21(9):
pubmed: 32365902
Front Pharmacol. 2017 Nov 01;8:779
pubmed: 29163165
Biol Psychiatry. 2007 Feb 1;61(3):348-58
pubmed: 16815322
Front Immunol. 2018 Jan 10;8:1957
pubmed: 29379504
Curr Psychiatry Rep. 2012 Aug;14(4):406-14
pubmed: 22644309
Mol Cell Proteomics. 2012 Feb;11(2):M111.012302
pubmed: 22126795
Therap Adv Gastroenterol. 2019 Oct 19;12:1756284819881304
pubmed: 31666808
Ann N Y Acad Sci. 2015 Sep;1349:83-95
pubmed: 25988664
Ann Neurosci. 2013 Oct;20(4):157-61
pubmed: 25206042
J Neuroinflammation. 2010 Dec 17;7:93
pubmed: 21167054
FEBS J. 2012 Apr;279(8):1375-85
pubmed: 22404766

Auteurs

Ewa Dudzińska (E)

Chair of Public Health, Medical University of Lublin, 20-090 Lublin, Poland.

Kinga Szymona (K)

Department of Psychiatry, Psychotherapy and Early Intervention, Medical University of Lublin, 20-439 Lublin, Poland.

Renata Kloc (R)

Laboratory of Cellular and Molecular Pharmacology, Chair and Department of Experimental and Clinical Pharmacology, Medical University of Lublin, 20-090 Lublin, Poland.

Tomasz Kocki (T)

Chair and Department of Experimental and Clinical Pharmacology, Medical University of Lublin, 20-090 Lublin, Poland.

Paulina Gil-Kulik (P)

Department of Clinical Genetics, Medical University of Lublin, 20-090 Lublin, Poland.

Jacek Bogucki (J)

Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 20-090 Lublin, Poland.

Janusz Kocki (J)

Department of Clinical Genetics, Medical University of Lublin, 20-090 Lublin, Poland.

Roman Paduch (R)

Department of Virology and Immunology, Maria Curie-Skłodowska University of Lublin, 20-033 Lublin, Poland.
Department of General Ophthalmology, Medical University of Lublin, 20-400 Lublin, Poland.

Ewa M Urbańska (EM)

Laboratory of Cellular and Molecular Pharmacology, Chair and Department of Experimental and Clinical Pharmacology, Medical University of Lublin, 20-090 Lublin, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH